These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 33055081)
1. Trajectories of COVID-19 information in the Annals of the Rheumatic Diseases: the first months of the pandemic. Lauper K; Bijlsma JWJ; Burmester GR Ann Rheum Dis; 2021 Jan; 80(1):26-30. PubMed ID: 33055081 [No Abstract] [Full Text] [Related]
2. Management of rheumatic diseases in the time of covid-19 pandemic: perspectives of rheumatology practitioners from India. Gupta L; Misra DP; Agarwal V; Balan S; Agarwal V Ann Rheum Dis; 2021 Jan; 80(1):e1. PubMed ID: 32299795 [No Abstract] [Full Text] [Related]
3. [Current guidance of the German Society of Rheumatology for the care of patients with rheumatic diseases during the SARS-CoV-2/Covid 19 pandemic]. Schulze-Koops H; Holle J; Moosig F; Specker C; Aries P; Burmester G; Fiehn C; Hoyer B; Krause A; Leipe J; Lorenz HM; Schneider M; Sewerin P; Voormann A; Wager U; Krüger K; Iking-Konert C; Z Rheumatol; 2020 May; 79(4):385-388. PubMed ID: 32342184 [TBL] [Abstract][Full Text] [Related]
4. How did COVID-19 pandemic changed the Portuguese rheumatology? Vieira-Sousa E; Fonseca JE; Santos MJ Acta Reumatol Port; 2020 Jun; 45(Jan-Mar (1)):5-6. PubMed ID: 32529820 [No Abstract] [Full Text] [Related]
5. Can hydroxychloroquine protect patients with rheumatic diseases from COVID-19? Response to: 'Does hydroxychloroquine prevent the transmission of COVID-19?' by Heldwein and Calado and 'SLE, hydroxychloroquine and no SLE patients with COVID-19: a comment' by Joob and Wiwanitkit. Monti S; Montecucco C Ann Rheum Dis; 2020 Jun; 79(6):e62. PubMed ID: 32327429 [No Abstract] [Full Text] [Related]
6. The Rheumatology Community responds to the COVID-19 pandemic: the establishment of the COVID-19 global rheumatology alliance. Wallace ZS; Bhana S; Hausmann JS; Robinson PC; Sufka P; Sirotich E; Yazdany J; Grainger R Rheumatology (Oxford); 2020 Jun; 59(6):1204-1206. PubMed ID: 32374851 [No Abstract] [Full Text] [Related]
8. National registry for patients with inflammatory rheumatic diseases (IRD) infected with SARS-CoV-2 in Germany (ReCoVery): a valuable mean to gain rapid and reliable knowledge of the clinical course of SARS-CoV-2 infections in patients with IRD. Hasseli R; Mueller-Ladner U; Schmeiser T; Hoyer BF; Krause A; Lorenz HM; Regierer AC; Richter JG; Strangfeld A; Voll RE; Pfeil A; Schulze-Koops H; Specker C RMD Open; 2020 Sep; 6(2):. PubMed ID: 32878994 [TBL] [Abstract][Full Text] [Related]
9. Clinical outcomes of Covid-19 in patients with rheumatic diseases and the effects of the pandemic on rheumatology outpatient care: A single-centre experience from Turkey. Batıbay S; Koçak Ulucaköy R; Özdemir B; Günendi Z; Göğüş FN Int J Clin Pract; 2021 Sep; 75(9):e14442. PubMed ID: 34105856 [TBL] [Abstract][Full Text] [Related]
10. Still early to define a clear role of antimalarial drugs for COVID-19 in patients with rheumatic disease. Response to: 'Hydroxychloroquine reduces the risk of covid-19 in patients with rheumatic diseases: myth or reality?' by Xie Gamboa-Alonso CM; Figueroa-Parra G; Galarza-Delgado DA Ann Rheum Dis; 2021 Jan; 80(1):e7. PubMed ID: 32571868 [No Abstract] [Full Text] [Related]
11. A bibliometric analysis of rheumatology and COVID-19 researches. Pasin O; Pasin T Clin Rheumatol; 2021 Nov; 40(11):4735-4740. PubMed ID: 34215906 [TBL] [Abstract][Full Text] [Related]
13. American College of Rheumatology Guidance for the Management of Rheumatic Disease in Adult Patients During the COVID-19 Pandemic: Version 1. Mikuls TR; Johnson SR; Fraenkel L; Arasaratnam RJ; Baden LR; Bermas BL; Chatham W; Cohen S; Costenbader K; Gravallese EM; Kalil AC; Weinblatt ME; Winthrop K; Mudano AS; Turner A; Saag KG Arthritis Rheumatol; 2020 Aug; 72(8):1241-1251. PubMed ID: 32349183 [TBL] [Abstract][Full Text] [Related]
14. [A cross sectional study on patients with inflammatory rheumatic diseases in terms of their compliance to their immunsuppressive medication during COVID-19 pandemic]. Schmeiser T; Broll M; Dormann A; Fräbel C; Hermann W; Hudowenz O; Keil F; Müller-Ladner U; Özden F; Pfeiffer U; Saech J; Schwarting A; Stapfer G; Steinchen N; Storck-Müller K; Strunk J; Thiele A; Triantafyllias K; Wassenberg S; Wilden E; Hasseli R Z Rheumatol; 2020 May; 79(4):379-384. PubMed ID: 32303821 [TBL] [Abstract][Full Text] [Related]
15. COVID-19 and the practice of rheumatology in Africa: big changes to services from the shockwave of a pandemic. Akintayo RO; Akpabio A; Kalla A; Dey D; Migowa A; Olaosebikan H; Bahiri R; El Miedany Y; Hadef D; Hamdi W; Oyoo O; Slimani S; Yerima A; Taha Y; Adebajo A; Adelowo O; Tikly M; Ghozlani I; Abdelghani KB; Fouad NA; Mosad D; El Mikkawy D; Abu-Zaid MH; Abdel-Magied RA; Ann Rheum Dis; 2021 Jun; 80(6):e100. PubMed ID: 32611599 [No Abstract] [Full Text] [Related]
17. [Rheumatology update 2020: the focus was on Covid-19]. Hügle T Rev Med Suisse; 2021 Jan; 17(723):214-218. PubMed ID: 33507664 [TBL] [Abstract][Full Text] [Related]
18. Use of Apremilast in Patients With Psoriatic Arthritis During the COVID-19 Pandemic: Comment on the Article by Mikuls et al. Bansal P; Goyal A; Cusick A; Aslam F Arthritis Rheumatol; 2021 Mar; 73(3):547-548. PubMed ID: 33142038 [No Abstract] [Full Text] [Related]
19. Rheumatology in a time of Coronavirus: lessons from our early experiences. Cronin O; Horne A; Ralston SH QJM; 2020 Oct; 113(10):715-716. PubMed ID: 32396603 [No Abstract] [Full Text] [Related]
20. Hydroxychloroquine reduces the risk of covid-19 in patients with rheumatic diseases: myth or reality? Xie W; Wang Y; Zhang Z Ann Rheum Dis; 2021 Jan; 80(1):e6. PubMed ID: 32317316 [No Abstract] [Full Text] [Related] [Next] [New Search]